Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Menopause affects hair and skin; more research needed for treatment.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.